The FDA expanded the approval for GSK’s vaccine to protect against RSV authorizing its use for at-risk adults as young as 50.
https://www.statnews.com/2024/06/07/gsk-rsv-vaccine-fda-expanded-approval-cdc-arexvy/?utm_medium=social&utm_source=mastodon&utm_campaign=mastodon_organic
STAT /
npub1ev…0tvkk
2024-06-10 20:45:27
Author Public Key
npub1evr7plejrksuyjd3xvvy63eugyjh5sf3jlt33wagqdwgcatxc95sw0tvkkPublished at
2024-06-10 20:45:27Event JSON
{
"id": "4162188ef9951a817e3a8672ab61a303afc15e2b8e1eb22e732f5f464533a1c8",
"pubkey": "cb07e0ff321da1c249b133184d473c41257a413197d718bba8035c8c7566c169",
"created_at": 1718052327,
"kind": 1,
"tags": [
[
"proxy",
"https://newsie.social/users/STAT/statuses/112594277335766336",
"activitypub"
]
],
"content": "The FDA expanded the approval for GSK’s vaccine to protect against RSV authorizing its use for at-risk adults as young as 50.\n\nhttps://www.statnews.com/2024/06/07/gsk-rsv-vaccine-fda-expanded-approval-cdc-arexvy/?utm_medium=social\u0026utm_source=mastodon\u0026utm_campaign=mastodon_organic",
"sig": "8a0442598aceb57ecd7a77dc36e3dd6531bb18fcdcd48e13c822be21309c55f4e6bd8f7d6ec666c3693ac81ddb925ba6b1088eb16bd467296aba77c1a63d5521"
}